The Impact of use of Energy Devices during Parenchymal Transection of the Liver: a multicenter randomized controlled trial

The Impact of use of Energy Devices during Parenchymal Transection of the Liver: a multicenter randomized controlled trial - EPL trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006044

Enrollment

210

Registered

2011-07-26

Start date

2011-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver tumor

Interventions

use of the energy device no use of the energy device

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients will undergo hepatectomy without biliary reconstruction. Disease: Hepatocellular carcinoma, intrahepatic cholangiocellular carcinoma, metastatic liver cancer, benign liver tumor 2)PS:0-2 3)adequate bone marrow, liver function and renal function 4)Patients agreed with this study.

Exclusion criteria

Exclusion criteria: 1)the size of tumor is less than 20mm in diameter and tumor is solitary, and located in the surface of the liver. 2)Patinets will undergo hepatectomy and other surgical procedures (excluded cholecystectomy) 3)Patients cannot understand this study. 4)Pregnancy patients 5)Doctors considered that patient was not eligible.

Design outcomes

Primary

Measure	Time frame
Proportion of cases to the blood loss over 1000ml between the 2 groups	—

Countries

Japan

Contacts

Public ContactNaoto Gotohda

National Cancer Center Hospital East Hepatobiliary pancreatic surgery

ngotohda@east.ncc.go.jp04-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026